Cobas pure integrated solutions is a new compact analyzer that combines three technologies in a single platform to simplify daily operations at labs with limited space and resources.
Roche announced the launch of cobas pure integrated solutions, a new compact analyzer that combines three technologies in a single platform to simplify daily operations at labs with limited space and resources.
With a footprint of 2 m2, the analyzer focuses on the automation of manual tasks by performing up to 870 tests per hour while providing a full clinical chemistry and immunochemistry assay menu, which includes more than 230 diagnostic tests, Roche said in a March 17, 2021 press release. Additionally, the analyzer provides fully standardized results and operation to Roche’s cobas pro, its analyzer for large labs, and is compatible with the cobas mobile solution, a tablet that allows users to interact with the analyzer from anywhere in the lab.
“During these challenging times, providing accurate and timely testing has never been more vital. Roche continues to invest heavily in laboratory innovation to help meet the changing demands of healthcare systems,” said Thomas Schinecker, CEO Roche Diagnostics, in the press release. “With the launch of cobas pure integrated solutions, we seek to simplify complex workflows in small-to-medium-sized labs so that laboratory professionals can focus on providing clinicians with the information they need to make reliable and timely clinical decisions for patients.”
Source: Roche
Clinical Supply Planning in Europe - Balancing Cost, Flexibility and Time
December 19th 2024The packaging and distribution of clinical supplies is a fundamental piece to the overall success of a clinical trial, and advance preparation can help establish a more efficient supply chain. Selecting the best geographical location for those activities, however, depends on the clinical trial protocol, business decisions, and even the investigational medicinal product (IMP) being studied.